Bnp Paribas Asset Management Holding S.A. Intra Cellular Therapies, Inc. Transaction History
Bnp Paribas Asset Management Holding S.A.
- $40.4 Billion
- Q3 2024
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 454,538 shares of ITCI stock, worth $43.1 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
454,538
Previous 344,646
31.89%
Holding current value
$43.1 Million
Previous $23.6 Million
40.89%
% of portfolio
0.08%
Previous 0.06%
Shares
3 transactions
Others Institutions Holding ITCI
# of Institutions
379Shares Held
84.1MCall Options Held
319KPut Options Held
143K-
Vanguard Group Inc Valley Forge, PA9.63MShares$913 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$600 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY5.29MShares$502 Million0.03% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.85MShares$365 Million1.4% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.05MShares$289 Million3.36% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $8.96B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...